Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) is -21.20% lower on its value in year-to-date trading and has touched a low of $36.56 and a high of $65.92 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AMPH stock was last observed hovering at around $48.86 in the last trading session, with the day’s loss setting it -0.12%.
Currently trading at $48.74, the stock is 8.84% and 16.30% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.21 million and changing -0.25% at the moment leaves the stock 2.71% off its SMA200. AMPH registered -10.34% loss for a year compared to 6-month loss of 5.45%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 14.82% gain in the last 1 month and extending the period to 3 months gives it a 15.14%, and is 1.65% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.63% over the week and 3.13% over the month.
Amphastar Pharmaceuticals Inc (AMPH) has around 1761 employees, a market worth around $2.37B and $712.89M in sales. Current P/E ratio is 15.53 and Fwd P/E is 11.15. Profit margin for the company is 23.36%. Distance from 52-week low is 33.32% and -26.07% from its 52-week high. The company has generated returns on investments over the last 12 months (12.52%).
The EPS is expected to grow by 19.53% this year.
Amphastar Pharmaceuticals Inc (AMPH) Top Institutional Holders
358.0 institutions hold shares in Amphastar Pharmaceuticals Inc (AMPH), with institutional investors hold 92.64% of the company’s shares. The shares outstanding are 48.07M, and float is at 35.02M with Short Float at 12.02%. Institutions hold 71.95% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 5.94 million shares valued at $237.7 million. The investor’s holdings represent 12.3258% of the AMPH Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 2.67 million shares valued at $$106.91 million to account for 5.544 of the shares outstanding. The other top investors are FEDERATED HERMES, INC. which holds 1.94 million shares representing 4.0339% and valued at over $77.79 million, while TD ASSET MANAGEMENT INC holds 3.5086 of the shares totaling 1.69 million with a market value of $67.66 million.
Amphastar Pharmaceuticals Inc (AMPH) Insider Activity
The most recent transaction is an insider sale by Zhou Rong,the company’sSENIOR EVP, PRODUCTION CENTER. SEC filings show that Zhou Rong sold 4,000 shares of the company’s common stock on Aug 26 ’24 at a price of $48.35 per share for a total of $0.19 million. Following the sale, the insider now owns 0.12 million shares.
Still, SEC filings show that on Aug 12 ’24, PRINS RICHARD K (Director) disposed off 17,101 shares at an average price of $43.07 for $0.74 million. The insider now directly holds 33,971 shares of Amphastar Pharmaceuticals Inc (AMPH).
